Upsher-Smith Laboratories Launches Tosymra(TM) (sumatriptan) Nasal Spray For The Acute Treatment Of Migraine In Adults

Delivers the Efficacy of an Injectable with the Convenience of a Nasal Spray MAPLE GROVE, Minn., Oct. 2, 2019 -- (Healthcare Sales & Marketing Network) -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Tosymra™ (sumatriptan... Biopharmaceuticals, Neurology, Drug Delivery, Product Launch Upsher-Smith Laboratories, Tosymra, sumatriptan, Migraine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news